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Abstract
Lipid mediators including classical arachidonic acid-derived eicosanoids (e.g.
prostaglandins and leukotrienes) and more recently identified specialized pro-
resolving-mediator metabolites of the omega-3 fatty acids play essential roles
in initiation, self-limitation, and active resolution of acute inflammatory
responses. In this study, we examined the bioactive lipid mediator profile of
human skeletal muscle at rest and following acute resistance exercise. Twelve
male subjects completed a single bout of maximal isokinetic unilateral knee
extension exercise and muscle biopsies were taken from the m.vastus lateralis
before and at 2, 4, and 24 h of recovery. Muscle tissue lipid mediator profile
was analyzed via liquid chromatography–mass spectrometry (LC-MS)-based
targeted lipidomics. At 2 h postexercise, there was an increased intramuscular
abundance of cyclooxygenase (COX)-derived thromboxanes (TXB2: 3.33 fold)
and prostaglandins (PGE2: 2.52 fold and PGF2a: 1.77 fold). Resistance exercise
also transiently increased muscle concentrations of lipoxygenase (LOX) path-
way-derived leukotrienes (12-Oxo LTB4: 1.49 fold and 20-COOH LTB4: 2.91
fold), monohydroxy-eicosatetraenoic acids (5-HETE: 2.66 fold, 12-HETE: 2.83
fold, and 15-HETE: 1.69 fold) and monohydroxy-docosahexaenoic acids (4-
HDoHE: 1.69 fold, 7-HDoHE: 1.58 fold and 14-HDoHE: 2.35 fold). Further-
more, the abundance of CYP pathway-derived epoxy- and dihydroxy-eicosa-
trienoic acids was increased in 2 h postexercise biopsies (5,6-EpETrE: 2.48
fold, 11,12-DiHETrE: 1.66 fold and 14,15-DiHETrE: 2.23 fold). These data
reveal a range of bioactive lipid mediators as present within human skeletal
muscle tissue and demonstrate that acute resistance exercise transiently stimu-
lates the local production of both proinflammatory eicosanoids and pathway
markers in specialized proresolving mediator biosynthesis circuits.
Introduction
Skeletal muscle is a remarkably heterogeneous tissue with
the capacity to adapt and respond to external stress. It is
well established that intense resistance exercise can lead to
improvements in muscle strength through changes in
muscle fiber type, myofibrillar hypertrophy, and neuro-
muscular mechanisms (Fl€uck 2006). However,
unaccustomed exercise, especially when comprising a
large eccentric component, can cause skeletal muscle
injury and initiate an acute inflammatory response (Arm-
strong et al. 1991; Faulkner et al. 1993; Tidball 1995).
Experimental models targeted at manipulating the postex-
ercise inflammatory response have identified that exer-
cise-induced inflammation is a key regulatory feature in
the normal process of tissue regeneration and adaptation
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following acute muscle damage (Urso 2013; Markworth
et al. 2014; Roberts et al. 2015). This suggests that molec-
ular signaling events occurring early during acute inflam-
mation play an active role in promoting the restoration
of normal tissue function and promote skeletal muscle
adaptation following an exercise stimulus.
The humoral and local muscular changes that occur
during exercise-induced inflammation closely resemble
that of an acute phase response to cellular stress. Exer-
cise stimulus triggers the production of proinflamma-
tory signaling molecules, establishing a chemotactic
gradient and the diapedesis as well as potential infiltra-
tion of inflammatory leukocytes (Paulsen et al. 2012).
These chemoattractants consist of lipid-derived media-
tors such as leukotrienes (LTs) and prostaglandins
(PGs), as well as protein mediators, including cytokines
and chemokines (Serhan et al. 2008). The usual out-
come of an acute inflammatory response is its success-
ful resolution and repair of damaged tissue (Serhan
and Savill 2005). Traditionally, the resolution of inflam-
mation was thought to be a passive process involving
the dilution and catabolism of pro-inflammatory media-
tors leading to the exodus of leukocytes from the site
of muscle damage. However, with the discovery of
novel classes of lipid-derived mediators, the resolution
of acute inflammation is now seen as an active and
finely controlled biochemical and metabolic process that
may provide a critical link between cellular stress and
tissue regeneration/adaptation (Levy et al. 2001; Bannen-
berg et al. 2005).
Lipid mediators are biosynthesized endogenously from
essential omega-6 (n-6) and omega-3 (n-3) polyunsatu-
rated fatty acids (PUFA) and are involved in a wide
range of physiological and pathophysiological processes
(Bannenberg et al. 2005). The majority of research in
postexercise inflammation has focused on classical pros-
taglandins (synthesized via cyclooxygenase (COX)
enzymes, COX-1 and COX-2) and leukotrienes (synthe-
sized via the 5-lipoxygenase (5-LOX) enzyme), which
are derived from the n-6 PUFA arachidonic acid (AA).
These lipid mediators play a diverse role in stimulating
acute inflammation by controlling local blood flow, vas-
cular permeability, cytokine production, leukocyte
chemotaxis, and sensation of pain (Markworth et al.
2013). On the other hand, a second class of eicosanoids
also generated from AA, termed the lipoxins (LX) (Ser-
han et al. 1995; Maddox and Serhan 1996; Ryan and
Godson 2010), together with more recently identified
eicosapentaenoic (EPA) (E-Series) and docosahexaenoic
acid (DHA) (D-Series)-derived resolvins (Rv), protectins
(PD) (Serhan et al. 2000, 2002, 2015; Hong et al. 2003;
Serhan 2006; Duvall and Levy 2016), and maresins
(MaR) (Serhan et al. 2009 & 2012) have been shown
to play proresolution functions following acute inflam-
mation. These novel lipid mediators, collectively termed
specialized proresolving mediators (SPMs), act to block
acute inflammatory signals by inhibiting proinflamma-
tory cytokine production and subsequent neutrophil
chemotaxis (Schwab et al. 2007; Serhan and Petasis
2011). They simultaneously promote the nonphlogistic
infiltration of blood monocytes/macrophages and stimu-
late tissue macrophages to phagocytize and clear apop-
totic neutrophils while promoting wound healing
(Maddox and Serhan 1996; Godson et al. 2000).
SPMs are formed during inflammatory transcellular
interactions, involving the sequential actions of two or
more cell types expressing the required LOX and/or COX
enzymes in a compartmentalized manner. During the
time-course of inflammation cell–cell interactions between
platelets, leukocytes, the vasculature and resident tissue
cells facilitates the transcellular biosynthesis of unique
SPMs (Markworth et al. 2016b). The temporal regulation
of these lipids is therefore specific to the tissue type, incit-
ing inflammatory stimulus (Levy et al. 2001; Bannenberg
et al. 2005). For example, LX biosynthesis involves cellu-
lar interactions between 5-LOX expressing neutrophils
with 12-lipoxygenase (12-LOX) expressing platelets or 15-
lipoxygenase (15-LOX) expressing M2 monocytes (Serhan
et al. 1984). Recent findings from Markworth et al.
(2013) demonstrated that SPMs, including lipoxins, resol-
vins, and protectins, were elevated in human blood serum
samples collected following an acute bout of resistance
exercise. Peak induction of proinflammatory mediators
including the prostaglandins and leukotrienes occurred
during the early stages of postexercise muscle recovery
(1–2 h), while elevated concentrations of specific SPMs
were detected during both early (0–3 h: LXA4/LXB4, RvE1
and RvD1) and later (24 h: PD1) stages of muscle recov-
ery. In this study, we used the same targeted lipidomics
approach to characterize the time-course of changes in
concentrations of eicosanoid and docosanoid species
locally within human skeletal muscle tissue following an
acute bout of resistance exercise. We aimed to identify
which species of bioactive lipid mediators are present
within skeletal muscle tissue and hence may be locally
generated and acting following an acute bout of resistance
exercise. We hypothesized that there would be a rapid
increase in pro-inflammatory prostaglandin and leuko-
triene biosynthesis, followed by the activation of SPM
pathways at the onset of inflammatory resolution. Identi-
fication of the lipid mediator profile of skeletal muscle
and ability of exercise stress to modulate intramuscular
bioactive lipids will help to contribute to the understand-
ing of a biologically active inflammatory resolution path-
way that may be essential to muscle recovery and
adaptation following an inflammatory event.
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Materials and Methods
Subjects
As previously described (Farnfield et al. 2009), fourteen
untrained but recreationally active men aged 18–25 years
were recruited to participate in the acute exercise study. A
subset of 12 male participants, for which sufficient muscle
biopsy tissue remained, were included in the analysis per-
formed here (Table 1). Exclusion criteria included partici-
pation in regular resistance exercise within one year prior
to commencing the study, and/or the consumption of any
nutritional or purported muscle-building supplements.
Each participant also completed a medical history ques-
tionnaire to identify any potential risk factors that would
prevent the subjects from completing strenuous exercise.
Ethics approval
Each participant was provided with a written and oral
explanation of the nature of the study and potential risks
of the experimental procedures before providing written
consent to participate. All procedures involved in the
study were formally approved by the Deakin University
Human Research Ethics Committee (DUHREC 2004-017)
and muscle biopsy procedures were performed in order
with Helsinki declaration.
Familiarization
At least 7 days prior to the trial day, each subject com-
pleted a familiarization session on the Cybex NORM
dynamometer (Cybex International Inc. UK). The session
involved performing isokinetic maximal voluntary con-
tractions (iMVC) during concentric and eccentric knee
extension exercise. Maximal force production measured
as peak torque (N.m) was determined at 60°/s over 12
maximal concentric and eccentric contractions. Subjects
were provided with verbal encouragement throughout the
test to ensure maximal effort.
Experimental design
On the morning of the trial, subjects reported to the lab-
oratory in an overnight fasted state having abstained from
alcohol, caffeine, and tobacco for the previous 24 h. Par-
ticipants rested in a supine position for 30 min, following
which a resting muscle biopsy sample was collected. Each
participant then completed an acute bout of maximal
concentric and eccentric isokinetic unilateral knee exten-
sion exercise on the Cybex NORM dynamometer. Sub-
jects completed three sets of 12 maximal voluntary
repetitions at a constant speed of 60°/s with 2 min of rest
between each set. Subjects were instructed to contract
maximally during each repetition and were provided with
verbal encouragement throughout each set. Further mus-
cle biopsy samples were obtained from the exercised leg
at 2 and 4 h after completion of the exercise protocol.
The following morning, subjects reported to the labora-
tory again in an overnight fasted state for a final follow
up 24 h postexercise muscle biopsy sample.
Muscle biopsy procedure
Muscle biopsy samples were obtained from the m.vastus
lateralis under local anesthesia (Xylocaine 1%) using a
percutaneous needle biopsy technique modified to include
suction (Buford et al. 2009). A section of excised tissue
was rapidly snap frozen in liquid nitrogen and stored at
80°C for further analysis. Repeat muscle biopsy samples
were collected from the same leg through separate inci-
sions separated by at least 2 cm from the previous biopsy
site to minimize the risk of any localized inflammation




Muscle biopsy samples were weighed and homogenized in
1 mL phosphate buffered saline (50 mmol/L phosphate
containing 0.9% sodium chloride, pH 7.4), using Zirco-
nium beads on a high-frequency oscillator (Precellys
homogenizer, Bertig Instruments). The homogenates were
centrifuged at 6000 g for 10 min and the supernatant was
collected for the extraction of fatty acyl lipid mediators
using C18 solid phase extraction cartridges as described
earlier (Markworth et al. 2013; Maddipati et al. 2014,
2016). Fatty acyl lipid mediator extracts were subjected to
LC-MS analysis essentially as described before (Mark-
worth et al. 2013, 2016a). Under the LC-MS conditions
employed, the detection limit for most of the lipid media-
tors was 1 pg on the column and the quantitation limit
was 5 pg on the column with a signal-to-noise ratio > 3.
Tissue weights from each sample (range: 14–70 mg, aver-
age: 43 mg, inter-quartile range: 32–56 mg) were used for
normalization of the LC-MS data and the data are
reported as ng per gram (ng/g) of tissue.
Table 1. Subject characteristics. Values are mean  SEM of n =
12 participants
Age (y) Height (cm) Body mass (kg) BMI (kg.m2)
22.1  0.6 178.8  2.2 74.6  2.6 23.3  0.7
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Statistics
Statistical analysis was performed using SigmaPlot v12.3
(Systat Software Inc, Chicago, IL). Data were analyzed
using a one-way repeated measures ANOVA. Following a
statistically significant main ANOVA effect, Student–New-
man–Keuls post hoc tests were used to determine the sig-
nificance of pair-wise comparisons between individual
time points. Data is presented as mean  standard error
of the mean (SEM). Statistical significance was set at
P < 0.05.
Results
Metabolipidomic profile of human skeletal
muscle tissue
Lipid mediator profiles of human skeletal muscle biopsies
were generated via targeted LC-MS/MS based metabolipi-
domics. Of the total 125 multiple reaction monitoring
(MRM) transitions, 84 unique lipid mediators were reli-
ably detected in resting skeletal muscle tissue (signal/noise
ratio > 3 in ≥ 50% of samples) (Table S1). Detected ana-
lytes included a range n-6 and n-3 PUFA metabolites
enzymatically derived from the COX, LOX, and CYP
pathways (Table S1). Metabolites of linoleic acid (LA,
18:2n-6) including hydroxy-octadecadienoic acid (9-, 13-
HODEs) and epoxy-octadecadienoic acids (9(10)-, 12
(13)-EpOMEs) were most abundant (50–100 ng/g), fol-
lowed by major enzymatic metabolites of the n-6 PUFA
AA (20:4n-6). Numerous metabolites of the n-3 PUFAs




COX enzymes catalyze the first step in the conversion of
AA to prostaglandins (PGE2, PGF2ɑ, PGD2, and PGI2)
and thromboxane (TXA2). TXA2 is highly unstable and
nonenzymatically decomposes to TXB2 and 12(S)-HHTrE.
Thus, both these metabolites serve as surrogate markers
of TXA2 biosynthesis. TXB2 and 12(S) HHTrE were both
detected within resting skeletal muscle tissue at concentra-
tions of 1.12 ng/g and 7.68 ng/g, respectively (Fig. 1). At
2 h postexercise, muscle TXB2 increased to 3.73 ng/g
(P = 0.002) (Fig. 1A) and 12(S)-HHTrE increased to
13.50 ng/g (P = 0.002) (Fig. 1B). The prostaglandins
PGE2 and PGF2ɑ were also detected in resting skeletal
muscle tissue at concentrations of 1.13 ng/g and 0.68 ng/
g, respectively. At 2 h postexercise, intramuscular PGE2
increased to 2.84 ng/g (P = 0.009) (Fig. 1C) and PGF2ɑ
increased to 1.20 ng/g (P = 0.013) (Fig. 1D). Intramuscu-
lar TXB2, 12(S)HHTrE, PGE2 and PGF2a were no longer
elevated above preexercise levels by 4 h and 24 h of
recovery from the exercise bout. Other major AA-derived
prostaglandins including PGD2 and PGI2 (measured as
the stable downstream nonenzymatic metabolite 6-keto-
PGF1a) were below the limit of detection of the assay
used here in human muscle biopsy samples collected both
before and after the resistance exercise intervention
(Table S1).
Omega-3 derived
The majority of 3-series (EPA derived) prostaglandins
were below the limit of detection of our assay in human
skeletal muscle tissue (Table S1). However, a downstream
bioactive metabolite of the EPA-derived PGD3, 15-Deoxy-
D12,14-prostaglandin J3, was detected at concentrations of
3.09 ng/g in resting muscle. Furthermore, 15-Deoxy-
D12,14-prostaglandin J3 increased 1.35 fold to concentra-
tions of 4.45 ng/g at 2 h postexercise (P = 0.010)
(Fig. 1E). 15-Deoxy-D12,14-prostaglandin J3 returned to
basal levels by 4 h (P = 0.764) and 24 h (P = 0.344).
Lipoxygenase pathways
5-LOX
The 5-LOX pathway primarily converts AA substrate to
5-hydroperoxy-eicosatetranoic acid (5-HpETE), which
can be reduced to 5-hydroxy-eicosatetranoic acid (5-
HETE), or undergo further metabolism via 5-LOX to
form the leukotrienes. 5-HETE was detected in resting
muscle at a concentration of 3.38 ng/g (Fig. 2A). Muscle
5-HETE levels increased at 2 h postexercise to 8.99 ng/g
(p = 0.017) (Fig. 2A). Leukotriene B4 (LTB4) was below
the level of detection of our assay in the majority of rest-
ing muscle biopsies, but was consistently detected at con-
centrations of ~3 ng/g at 2 h of recovery from the bout
of resistance exercise (Fig. 2B). Furthermore, downstream
degradation products of LTB4, including 12-Oxo-LTB4
and 20-COOH-LTB4 were both detected in resting muscle
and increased in abundance at 2 h postexercise to con-
centrations of 2.29 ng/g (P < 0.041) (Fig. 2C) and
5.33 ng/g (P < 0.001) (Fig. 2D), respectively. Intramuscu-
lar 5-LOX products of AA including 5-HETE, 12-Oxo-
LTB4 and 20-COOH-LTB4 were no longer increased
above basal levels at 4 h or 24 h of recovery.
12-LOX
The 12-LOX enzyme is expressed primarily in human pla-
telets and metabolizes AA to form 12-hydroxy-
2019 | Vol. 7 | Iss. 13 | e14108
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eicosatetraenoic acid (12-HETE), which is a key stimula-
tor of leukocyte chemotaxis and platelet aggregation
(Dobrian et al. 2011; Yeung and Holinstat 2011; Yin et al.
2011). 12-HETE was by far the most abundant monohy-
droxylated-FA product detected in resting muscle tissue,
present at concentrations of 22.51 ng/g. Muscle 12-HETE
further increased above resting levels at 2 h postexercise
to concentrations of 63.81 ng/g (P = 0.01) (Fig. 3A).
Tetranor 12-HETE, a downstream degradation product of
12-HETE, was also detected in resting muscle tissue at
lower concentrations of 0.62 ng/g and increased markedly
at 2 h postexercise to reach intramuscular concentrations
of 3.97 ng/g (P = 0.006) (Fig. 3B). Furthermore, the 12-
LOX metabolites of n-3 EPA, 12-hydroxy-eicosapen-
taenoic acid (12-HEPE) was present in resting muscle
biopsies and increased at 2 h postexercise (P = 0.016)
(Fig. 3C). By 4 h and 24 h of recovery, intramuscular 12-
LOX products including 12-HETE, tetranor 12-HETE,
and 12-HEPE no longer differed from resting levels.
15-LOX
The 15-LOX pathway converts AA to 15-hydroxy-eicosate-
tranoic acid (15-HETE) (Wuest et al. 2012). 15-HETE was
detected in resting muscle at 3.84 ng/g. Muscle 15-HETE
tended to increase at 2 h postexercise to 6.50 ng/g, but this
did not achieve statistical significance (P = 0.10) (Fig. 4A).
The 15-LOX metabolite of n-3 EPA, 15-hydroxy-eicos-
apentaenoic acid (15-HEPE) was also detected in resting
muscle tissue, but was not influenced by the exercise inter-
vention (main effect P = 0.308) (Fig. 4B).
Docosanoids
In addition to the 20-carbon PUFA AA and EPA, LOX
pathway converts the 22-carbon n-3 PUFA DHA to doco-
sanoid metabolites which most notably are key pathway
markers and intermediates in the biosynthesis of the SPM
family of bioactive lipid mediators.
Figure 1. Metabolites of the cyclooxygenase (COX) pathway derived from arachidonic acid and eicosapentaenoic acid. Values depicted are
mean values  SEM. * denotes statistical significance compared to pre-exercise values (P < 0.05).
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The 5-LOX enzyme oxidizes n-3 DHA to form the
monohydroxylated-DHA (HDoHE) products 4-hydroxy-
docosahexanoic acid (4-HDoHE) and 7-hydroxy-docosa-
hexanoic acid (7-HDoHE). Both 4- and 7-HDoHE were
detected in resting muscle at concentrations of 2.23 ng/g
(Fig. 5A) and 0.98 ng/g (Fig. 5B), respectively. 7-HDoHE
increased at 2 h postexercise to 1.54 ng/g (P = 0.008)
(Fig. 5B). Similarly, muscle 4-HDoHE tended to increase
from preexercise levels at 2 h postexercise (P = 0.069), and
was statistically greater at 2 h compared than both 4 h
(P = 0.011) and 24 h (P = 0.016) of recovery (Fig. 5A).
The 12-LOX enzyme converts the 22-carbon DHA to 14-
hydroperxy-docosahexanoic acid (14-HpDoHE), which
can then be reduced to 14-HDoHE or metabolized to form
the maresins (MaR 1 & 2) via the further action of 12-LOX.
Similarly, the 15-LOX enzyme converts DHA to 17-hy-
droxy-docosahexanoic acid (17-HDoHE) which can be
converted into the D-series resolvins via the subsequent
action of 5-LOX. Therefore, 14-HDoHE and 17-HDoHE
are pathway markers of increased MaR and RvD biosynthe-
sis, respectively. We detected 14-HDoHE in resting skeletal
muscle at a concentration of 0.68 ng/g (Fig. 5C). Muscle
14-HDoHE increased at 2 h postexercise to concentrations
of 1.60 ng/g (P = 0.005) (Fig. 5C). In contrast, 17-HDoHE
was not found to be present at detectable concentrations
within human muscle biopsies at rest or at any time-point
throughout exercise recovery (Table S1).
Multiple reaction monitoring (MRM) transitions corre-
sponding to mature SPMs including the lipoxins (LXA4,
LXB4, LXA5), E-series resolvins (RvE1 & RvE3), D-series
resolvins (RvD1, RvD2, RvD5, RvD6), protectins (PD1 &
10S,17S-DiHDoHE) and maresins (MaR1) were addition-
ally monitored by our LC-MS/MS assay. Resting muscle
tissue was found to contain low but detectable concentra-
tions of RvD6 (1.04 ng/g), PD1 (0.64 ng/g) and MaR1
(0.75 ng/g). The greatest average intramuscular concen-
trations of RvD6 (1.81 ng/g), PD1 (2.58 ng/g), and MaR1
(1.33 ng/g) were observed at 2 h postexercise. Despite
this, the low and sporadic concentrations in certain sub-
jects at particular time-points, combined with our
repeated measures study design, precluded statistical anal-
ysis. Other mature SPMs including LXA4, LXB4, LXA5,
RvD1, RvE3, RvD1, RvD2, RvD5 and the protectin D1
isomer 10S,17S-DiHDoHE were not found to be present
at detectable levels locally within human muscle tissue
biopsies at rest or throughout 24 h of postexercise recov-
ery under the conditions used here (Table S1).
Epoxygenase pathway
The cytochrome P-450 (CYP) enzymes metabolize n-6
PUFA AA to a family of epoxyeicosatrienoic acid (EpE-
TrE) regioisomers. Once formed, these bioactive EpETrEs
are rapidly metabolized by the soluble epoxide hydrolase
(sEH) enzyme to form corresponding downstream dihy-
droxyeicosatrienoic acids (DiHETrEs) vicinal diols. AA
epoxides including 5,6-, 8,9-, 11,12- and 13,14-EpETrE,
were detected in resting muscle tissue at concentrations
Figure 2. Metabolites of the 5-lipoxygenase (5-LOX) pathway derived from arachidonic acid. Values depicted are mean values  SEM. *
denotes statistical significance compared to preexercise values (P < 0.05).
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between 3 and 10 ng/g. Despite this, 5,6-EpETrE was the
only primary enzymatic epoxy AA-metabolite that showed
an effect for the exercise intervention, increasing threefold
to 14.12 ng/g at 2 h postexercise (P < 0.003) (Fig. 6A).
Downstream epoxide products of the sEH enzyme, 11,12-
DiHETrE and 14,15-DiHETrE were present at much
lower absolute concentrations in resting muscle (~1 ng/
g), but increased in response to exercise with a peak
response at 2 h of recovery (11,12-DiHETrE P = 0.026,
14,15-DiHETrE P = 0.011) (Fig. 6B and C). The 5,6-
DiHETrE regioisomer was also detected at low levels in
resting muscle, but was unchanged during postexercise
recovery (Table S1).
CYP epoxidase enzymes also have the capacity to
metabolize the n-6 linoleic acid to bioactive lipid media-
tors including 9(10)-EpOME and 12(13)-EpOME and
their downstream sEH products 9(10)-DiHOME and 12
(13)-DiHOME. Both 9(10)- and 12(13)-EpOME were
highly abundant in resting human muscle present at con-
centrations of 100.87 ng/g and 54.36 ng/g, respectively,
but were not influenced by the exercise intervention
(Table S1). In contrast, 9(10)- and 12(13)-DiHOME were
present at lower concentrations in resting muscle, but
increased significantly at 2 h postexercise (P = 0.034 and
P = 0.020 respectively) (Fig. 7). CYP pathway metabolites
of both AA and LA no longer differed from preexercise
levels by 4- and 24-h of postexercise recovery.
Discussion
The study explored the intramuscular lipid mediator
response following an acute bout of resistance exercise.
We identified 84 unique lipid mediators as present within
skeletal muscle tissue. The early postexercise response was
characterized by increased tissue concentrations of a range
of bioactive lipid derivatives of the cyclooxygenase (COX-
Figure 3. Metabolites of the 12-lipoxygenase (12-LOX) pathway
derived from arachidonic acid and eicosapentaenoic acid. Values
depicted are mean values  SEM. * denotes statistical significance
compared to preexercise values (P < 0.05).
Figure 4. Metabolites of the 15-lipoxygenase (15-LOX) pathway derived from arachidonic acid and eicosapentaenoic acid. Values depicted are
mean values  SEM. * denotes statistical significance compared to preexercise values (P < 0.05).
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1 & 2), lipoxygenase (5-, 12- & 15-LOX), and epoxyge-
nase (CYP) pathways. Unexpectedly, however, peak
induction of both proinflammatory and SPM pathway
intermediates occurred simultaneously at 2 h of recovery.
The findings from this study identify a complex parallel
adaptive lipid response to resistance exercise that may
play an essential role in regulating the onset and resolu-
tion of acute exercise-induced skeletal muscle inflamma-
tion.
This is the first paper to use a targeted lipidomics
approach to extensively characterize the lipid mediator
profile of human skeletal muscle tissue at rest and in
response to acute exercise. The majority of human
research exploring the effect of exercise on lipid species
has focused primarily on a select few prostaglandins,
specifically PGE2 and PGF2ɑ, likely due to their complex
role in regulating acute inflammation, perceptions of pain
and purported roles in muscle cell growth/regeneration
(Karamouzis et al. 2001a, 2001b; Trappe et al. 2001,
2006). Although some studies have reported elevated cir-
culating levels of PGE2 following exercise-induced muscle
injury (Dousset et al. 2007; Uchida et al. 2009; Tartibian
et al. 2011; Markworth et al. 2013), these findings have
not yet been replicated in skeletal muscle tissue (Trappe
et al. 2001; Paulsen et al. 2010). PGF2ɑ increases locally
within skeletal muscle tissue following both eccentric
(Trappe et al. 2001) and isotonic resistance exercise pro-
tocols (Trappe et al. 2006). It plays a significant role in
in vitro myofiber hypertrophy (Markworth and Cameron-
Figure 5. Metabolites of the lipoxygenase pathways derived from
docosahexaenoic acid. Values depicted are mean values  SEM. *
denotes statistical significance compared to pre-exercise values
(P < 0.05). ^ denotes statistical significance compared to 4 and
24 h postexercise values (P < 0.05).
Figure 6. Metabolites of the epoxygenase pathway derived from
arachidonic acid. Values depicted are mean values  SEM. *
denotes statistical significance compared to preexercise values
(P < 0.05).
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Smith 2011) and postexercise muscle protein synthesis
(Trappe et al. 2002). We previously found a significant
increase in serum levels of the circulating PGF2ɑ metabo-
lite 15-keto-PGF2ɑ early (1 h) following resistance exercise
in humans (Markworth et al. 2013). In this study, PGE2
and PGF2ɑ were the most abundant AA-derived PGs
detected within muscle tissue and both transiently
increased in abundance at 2 h following resistance exer-
cise. Furthermore, intramuscular production of TXA2
(measured by local TXB2 and 12(S)-HHTrE concentra-
tions) increased at 2 h postexercise. This finding within
the exercised musculature is consistent with prior reports
of transiently increased systemic TXB2 concentrations fol-
lowing both acute maximal aerobic (Laustiola et al. 1984)
and resistance exercise (Markworth et al. 2013). COX
enzymes are also able to metabolize linoleic acid to form
hydroxyoctadecadienoic acids (HODEs), which function
stimulate the maturation of monocytes to form macro-
phages. Previous research has identified an increase in
plasma in 9- and 13-HODE following 75 km of cycling
(Nieman et al. 2018), however this study is the first to
detect an increase in 9- and 13- HODEs in skeletal mus-
cle tissue following acute resistance exercise.
Another major metabolic pathway leading to the for-
mation of lipid species involved in the regulation of
inflammation is the 5-lipoxygenase pathway. 5-LOX-
derived LTB4 is increased in human blood serum follow-
ing acute resistance exercise (Markworth et al. 2013) and
high speed running (Hilberg et al. 2005). LTB4 is a potent
neutrophil chemoattractant and a powerful stimulator of
vasoconstriction and blood vessel permeability (Massoumi
and Sj€olander 2007). Expression of 5-LOX is essentially
limited to bone-marrow-derived cells including inflamma-
tory neutrophils and monocytes/macrophages (Rouzer
et al. 1989). It is therefore not surprising that in this
study LTB4 was very lowly expressed in skeletal muscle
tissue prior to exercise. At 2 h postexercise, LTB4 was
present at detectable concentrations in muscle biopsies
from the majority of subjects, indicative of a potential
increase from resting levels. Consistently, downstream
derivatives of LTB4, including 12-Oxo LTB4 and 20-
COOH LTB4, increased above resting levels at 2 h postex-
ercise. A less well-described branch of the 5-LOX pathway
involves the metabolism of 22-carbon n-3 PUFA DHA to
form mono-hydroxylated fatty acids 4- and 7-HDoHE.
Both of these fatty acids were detected in resting skeletal
muscle tissue and increased above basal levels at 2 h pos-
texercise. On the other hand, we observed no change in
4- or 7-HDoHE during recovery from resistance exercise
in human blood serum samples previously (Markworth
et al. 2013).
In addition to 5-LOX, metabolites of the human plate-
let type 12-LOX enzyme 12-HETE and its downstream
derivate tetranor 12-HETE were also elevated within mus-
cle postexercise. Both metabolites are pro-inflammatory
in nature and act transcellularly to modify the responsive-
ness of neutrophils to other chemotactic factors (Reynaud
and Pace-Asciak 1997). We previously observed a similar
increase in 12-HETE and downstream tetranor 12-HETE
in human blood serum samples during recovery from
resistance exercise (Markworth et al. 2013). Interestingly
12-LOX-expressing platelets are implicated in the tran-
scellular biosynthesis of pro-resolution LX mediators
through interactions with 5-LOX expressing PMNs. This
pathway involves leukocyte–platelet interactions during
which the 5-LOX-derived leukotriene intermediate LTA4
is taken up by 12-LOX expressing platelets for subsequent
conversion to LXA4 (Serhan and Sheppard 1990; Romano
et al. 1993). Further, the 15-LOX pathway is implicated
as a second endogenous route of LX biosynthesis species.
15-LOX is highly expressed in alternatively activated
macrophages and epithelial cells. The secretion of the 15-
LOX product, 15-HETE, can be taken up by 5-LOX
expressing cells and converted to LXA4 and LXB4 (Serhan
1989). In this study, we observed a trend toward an
increase in 15-HETE 2 h postexercise, which supports our
prior observation in human blood serum samples (Mark-
worth et al. 2013). The simultaneous induction of the
Figure 7. Metabolites of the epoxygenase pathway derived from linoleic acid. Values depicted are mean values  SEM. * denotes statistical
significance compared to preexercise values (P < 0.05).
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primary products of both the 5-LOX/12-LOX and 15-
LOX/5-LOX pathways within skeletal muscle during pos-
texercise recovery is presumably a permissive environment
for local LX biosynthesis. We were, however, unable to
detect LXA4 or LXB4 themselves within the muscle biopsy
homogenates analyzed here. Nevertheless, these local
changes within the exercised musculature suggests that
skeletal muscle tissue may potentially contribute to the
previously reported systemic lipoxin response to resis-
tance exercise following their release from exercised myo-
fibers (Markworth et al. 2013).
The CYP pathway is a third and less well-characterized
branch of the AA metabolic pathway. The increase in
epoxyeicosatrienoic acid regioisomer 5-6-EpETrE and
dihydroxyeicosatrienoic acids 11,12- and 14,15-DiHETrE
in skeletal muscle supports observations made in serum
samples when measured during the early stages of postex-
ercise inflammation (Markworth et al. 2013). The physio-
logical function of these derivatives remains unexplored
in skeletal muscle tissue. However, in vascular smooth
muscle and endothelium cells they play anti-inflammatory
roles through in the inhibition of prostaglandin and cyto-
kine induced inflammatory responses (Spector et al.
2004). CYP enzymes also metabolize linoleic acid via
epoxidation to form epoxy-octadecanoic acids (EpOMEs).
EpOMEs are rapidly hydrolyzed by the sEH enzyme to
form corresponding dihydroxy-octadecanoic acids
(DiHOMEs) (Konkel and Schunck 2011). EpOMEs and
DiHOMEs are leukotoxins that play a role in the suppres-
sion of neutrophil respiratory burst activity, vasodilation
and cellular apoptosis (Thompson and Hammock 2007;
Nieman et al. 2014). A cycling-based intervention com-
prising of a 75 km time trial had no effect on 9-10,
DiHOME 1.5 h and 21 h postexercise in plasma samples
of competitive road cyclists (Nieman et al. 2014). Alterna-
tively, a bout of acute resistance exercise triggered an
increase in 9(10)-EpOME and 9-10,DiHOME in serum
samples (Markworth et al. 2013). Results from this study
showed an increase in 9,10-DiHOME and 12,13-
DiHOME, suggesting that discrepancies in the previous
literature may be due to the differences in the type of
exercise performed and the training status of the subjects.
Collectively, these findings demonstrate an increase in
bioactive lipid-derived mediators of the COX, LOX, and
CYP pathways during postexercise muscle recovery. The
concept of a biologically active inflammatory resolution
program governed by lipid derivatives was first proposed
in a TNF-ɑ-stimulated model of acute inflammation in
the murine air pouch (Levy et al. 2001). Within this
model, early formation of LTB4 and PGE2 at the onset of
inflammation was succeeded by a class-switching of eico-
sanoids to LXA4. During this process, interactions
between inflammatory and host tissue cells enabled the
biosynthesis of resolution mediators (Levy et al. 2001).
Alternatively, in a model of zymosan-A stimulated murine
peritonitis, the onset of inflammation was characterized
by a concomitant increase in LTB4 and LXA4 followed by
a late appearance of PGE2 at the onset of resolution (Ban-
nenberg et al. 2005). These findings demonstrate that the
temporal regulation of lipids and their role in inflamma-
tion is likely cell-type and stimulus specific. Recent work
from our group profiled the human lipid response to
acute resistance exercise in serum samples (Markworth
et al. 2013). This study showed an increase in key prosta-
glandin, leukotriene, lipoxin, and resolvin species during
the early stages of acute inflammation (1–3 h), followed
by an increase in 15-LOX derivatives and some prosta-
glandin metabolites (6-keto-PGF1ɑ and 13,14dh-15kPGE2)
24 h postexercise (Markworth et al. 2013). The present
finding of increased intramuscular abundance of bioactive
lipid mediators at 2 h postexercise is overall consistent
with findings from serum samples (Markworth et al.
2013), suggesting that muscle may be a major source of
blood lipid mediators. Interestingly lipid species that
require transcellular interactions, including lipoxins, resol-
vins, and protectins, were either undetected, or very lowly
expressed in skeletal muscle tissue, disproving the original
hypothesis predicting a delayed increase in SPMs coinci-
dent with the resolution of acute inflammation. These
lipids were detectable previously in human serum samples
during postexercise recovery and play a vital role in the
active resolution of acute inflammation (Markworth et al.
2013).
Conclusion
This is the first study to characterize the lipid mediator
profile of human skeletal muscle tissue at rest and follow-
ing acute resistance exercise. We identified an increase in
lipids autocoids derived from the COX, LOX, and CYP
pathways. Peak induction of AA-derived classical proin-
flammatory prostaglandins (TXB2, PGE2 and PGF2ɑ) and
leukotrienes (LTB4, 12-Oxo LTB4 and 20-COOH LTB4)
occurred at 2 h postexercise. Further various derivatives
of the 5-LOX (5-HETE, 4-HDoHE, and 7-HDoHE), 12-
LOX (12-HETE, tetranor 12-HETE, and 14-HDoHE) and
15-LOX (15-HETE) pathways were identified in abun-
dance in skeletal muscle tissue at 2 h postexercise and
may resemble transient cellular intermediates for the for-
mation of pro-resolution lipoxin and resolvin species. In
alternative models of acute inflammation, these lipids are
involved in coordinating a biologically active inflamma-
tory resolution program that is mechanistically linked to
tissue healing. This study was limited in that the analysis
was performed during the first 24 h of postexercise recov-
ery. Later time points may provide insight into an
2019 | Vol. 7 | Iss. 13 | e14108
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ongoing cascade of complex lipidomic alterations (Serhan
et al. 2007, 2008; Ryan and Godson 2010). This study
represents a descriptive analysis of the skeletal muscle
lipid response to acute resistance exercise. Further mecha-
nistic research exploring the physiological significance and
function of these lipids, both locally within skeletal mus-
cle tissue and following their systemic release, will be use-
ful in further characterizing the significance of the
intramuscular inflammatory response in postexercise
muscle recovery.
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